Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00224_DB06207_nanopub.RAvCaToA2Ed3OytRm7jf7tWQGCTOn_9Fk2Wza_jUqzORg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00224_DB06207 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00224_DB06207 label "DDI between Indinavir and Silodosin - Indinavir is a strong inhibitor of CYP3A4 may increase the serum concentration of silodosin by decreasing its metabolism thus increases the potential for adverse side effects. Combination therapy is contraindicated. [drugbank_resource:DB00224_DB06207]" assertion.
- drugbank_resource:DB00224_DB06207 identifier "drugbank_resource:DB00224_DB06207" assertion.
- drugbank_resource:DB00224_DB06207 title "DDI between Indinavir and Silodosin - Indinavir is a strong inhibitor of CYP3A4 may increase the serum concentration of silodosin by decreasing its metabolism thus increases the potential for adverse side effects. Combination therapy is contraindicated." assertion.
- drugbank:DB00224 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB06207 assertion.
- drugbank:DB06207 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB06207 assertion.